Spontaneous secondary pneumothorax (SSP) is a known complication and can occur during an acute exacerbation of chronic obstructive pulmonary disease (COPD) to confuse an unsuspecting physician. These patients have limited cardiopulmonary reserve, so can deteriorate quickly and require urgent management. We describe a unique case of SSP that occurred during an acute exacerbation of COPD, to remind physicians of this possibility and to re-examine their patients who are not improving as expected with nebulisation therapy.
INTRODUCTION
The prevalence of chronic obstructive pulmonary disease (COPD) was estimated to be 3.5% and as high as 9% in Singapore and the United States respectively 1, 2 . Most COPD exacerbations are treated easily in an outpatient setting, but complications such as secondary spontaneous pneumothorax (SSP) can be the presenting feature in some cases. Chronic obstructive pulmonary disease is the most common cause of SSP. Fifty to seventy percent of SSP in case series are attributed to COPD [3] [4] [5] , and rupture of apical blebs is the usual cause.
Secondary spontaneous pneumothorax occurs in later life compared to primary spontaneous pneumothorax. Secondary spontaneous pneumothorax occurs in the context of underlying lung disease and frequently requires urgent management due to limited cardiopulmonary reserve 6 . There is a four-fold mortality in COPD patients 7 . As recurrence is seen in up to 50% of patients with SSP, patients should be considered for preventive intervention such as pleurodesis 7 .
CASE REPORT
We describe a patient who was admitted to the nursing home unit of Bright Vision Hospital (BVH), Singapore. Mr. L was a 70-year old Chinese man and a retired businessman. He was a heavy smoker of 80 pack years with multiple admissions for COPD exacerbations. Although his last documented spirometry in 2008 showed a FEV1 of 31%, his lung function likely continued to worsen from smoking, eventually requiring long-term oxygen therapy in 2010. Mr. L was diagnosed with end-stage COPD by the respiratory physician in July 2012 and admitted to the inpatient hospice at BVH. In BVH hospice, Mr. L was on a fentanyl patch 100 μg/hour with breakthrough mist morphine 15 mg up to one hourly on an as needed basis for symptom control of dyspnea. He was later transferred to the nursing home unit of BVH as he had survived beyond his original prognosis of less than three months.
His past medical history also included old pulmonary tuberculosis 30 years ago for which he completed treatment, ischaemic heart disease with ST elevation myocardial infarction in 2008 status post percutaneous coronary intervention to the right coronary artery.
His stay was uneventful until he developed a fever with productive cough and physical signs of a chest infection. He became more dyspnoeic at rest but was able to maintain his saturations at 95% with 2 litres O 2 per minute. A diagnosis of pneumonia was made and he was started on oral augmentin by the resident medical officer. Two days later, Mr. L became more tachypnoeic and his saturations dropped to 88% on 2 l O 2 per minute. The medical officer on duty attended to Mr. L and noted expiratory rhonchi in both lungs. Jugular venous pressure was not elevated and there was no pedal oedema. An electrocardiogram showed sinus tachycardia, without hyper acute changes suggestive of acute myocardial infarction. A diagnosis of acute exacerbation of COPD was made. Oxygen was increased to 4 l per minute and intravenous hydrocortisone and a stat nebulization with salbutamol:ipratropium bromide:normal saline 2 ml:2 ml:1 ml was given by the medical officer. There was good initial response and his saturations improved to 95% on 4 l O 2 per minute. Blood specimens were taken for cultures and sensitivity. On review by the first author (Registrar on duty), Mr. L was still tachypnoeic and having expiratory rhonchi, and a second nebulisation was ordered. While giving the second nebulisation, his saturation continued to drop to 68% on 4 l O 2 per minute. He was then placed on 100% non-rebreather mask. As Mr. L had continued to deteriorate despite appropriate therapy for COPD exacerbation, he was re-examined for other causes of desaturations including non-respiratory causes such as acute myocardial infarction and congestive cardiac failure. The jugular venous pressure was not elevated and reduced breath sounds on the right lung were detected, although percussion did not show obvious hyper-resonance. His trachea was central and blood pressure was maintained at 145/75 mmHg with a heart rate of 110 beats per minute. A diagnosis of possible secondary spontaneous pneumothorax was made and an emergency ambulance was arranged to transfer him to the emergency department for a chest tube insertion. Mr. L was confirmed to have a spontaneous secondary pneumothorax on chest radiograph (Fig. 1) , and a chest tube was inserted (Fig. 2) .
Retrieval of his previous thoracic computed tomography scan showed extensive emphysema with bullae in the upper lobes, more on the right side ( Fig. 3 ). There was also scarring with granuloma formation in the lung apices secondary to previous Proceedings of Singapore Healthcare  Volume 23  Number 2  2014 tuberculosis infection. There were no bronchiectasis changes that might have contributed to spontaneous secondary pneumothorax.
DISCUSSION
We have described a case of SSP that occurred in a patient with an acute COPD exacerbation. Mr. L had presented with an acute exacerbation of COPD secondary to pneumonia with clear signs and symptoms as recorded by the medical team. There was also good initial response to nebulisation with salbutamol and ipratropium. When the patient further deteriorated, he was re-examined for other causes of hypoxaemia. Important differential diagnoses to be considered in a COPD patient include other respiratory causes such as secondary spontaneous pneumothorax or pulmonary embolism; cardiac causes such as arrhythmias, acute myocardial infarction or congestive cardiac failure; and medication causes such as excessive narcotics causing respiratory depression. A secondary spontaneous pneumothorax was diagnosed when the patient was re-examined for non-response to appropriate therapy.
Verbal communications with the respiratory physicians did not suggest a pathophysiological basis for nebulisation therapy in causing SSP. An extensive literature search also did not identify any case reports or trials that examined if nebulisation therapy given to COPD patients with bullae placed them at increased risk of spontaneous pneumothorax; or to suggest an association between nebulisation therapies and development of a spontaneous pneumothorax. There has been only one case report that described a patient who developed a spontaneous tension pneumothorax during an acute exacerbation of COPD 8 . Our case report hopes to remind physicians of this possibility, and to remain alert to re-examine their patients for SSP when they do not improve as expected with appropriate therapy. The importance lies in that, should the patient with unsuspecting pneumothorax be intubated and mechanically ventilated, positive pressure ventilation would result in a potentially fatal tension pneumothorax. Chronic obstructive pulmonary disease patients also have limited cardiopulmonary reserve, and can deteriorate quickly and require urgent management.
CONCLUSION
Spontaneous secondary pneumothorax is a known complication and can occur during an acute exacerbation of COPD. Physicians need to be alert to the development of such complications and re-examine their patients who deteriorate despite adequate therapy for COPD exacerbation. Positive pressure ventilation to an unsuspecting pneumothorax could result in a fatal tension pneumothorax. These patients also require urgent management due to limited cardiopulmonary reserve.
